Answers are grounded in this paper and cite their sources.
Systematic review presents disparities in multiple myeloma outcomes in Sub-Saharan Africa, suggesting urgent needs in care equity.
MM and MGUS impose a substantial and under-recognised burden in SSA, with poorer survival outcomes compared with global averages. The high rates of delayed presentation, limited diagnostic capacity, absence of routine plasma cell disorder screening and restricted access to modern therapies likely contribute to the disparities observed. Strengthening diagnostic infrastructure and improving early detection and treatment pathways are urgently needed to advance equity in myeloma care across SSA.
No takes yet. Share an insight, caveat, or question.
Ojo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: